Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for MHC II
Most Correlated Studies
- Regulatory T cells (Tregs, CD4+ TCRB+ CD25+) from CD3e- MHC II- or CD3e- MHC II+ recipient mice
- Dendritic cells (CD11c+ MHC II+ LY6G+) of C57BL/6 mice
- T cells adoptively transferred sorted from lymph nodes after moth cytochrome c protein treatment
- Peripheral blood monocytes response to soluble MHC Class II
- Cardiac purkinje (CNTN2+) cells versus ventricular myocytes (a-MHC+) gene profile
Most Relevant Literature
- MHC II immunogenicity shapes the neoepitope landscape in human tumors.
- MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange.
- Small-molecule MHC-II inducers promote immune detection and anti-cancer immunity via editing cancer …
- TRIM22 negatively regulates MHC-II expression.
- Combining Sequence Similarity with Physicochemical Properties to Predict Binders for MHC-II Molecule…
Most Relevant Clinical Trials
- Nivolumab Plus Relatlimab or Ipilimumab in Metastatic Melanoma Stratified by MHC-II Expression
- Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 Diabetes
- Vorinostat, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage …
- Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients
- Imiquimod and Tumor Lysate Vaccine Immunotherapy in Adults With High Risk or Recurrent Grade II Glio…
